Michael S. Rafii

Pediatrics, Perinatology and Child Health · 2020–2024

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Michael S. Rafii trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. M. Bull

Papers from Michael S. Rafii's perspective

Ordered by how strongly the researchers Michael S. Rafii trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Donanemab in Early Alzheimer's Disease. (New England Journal of Medicine)
  2. Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease (The journal of prevention of Alzheimer's disease)
  3. Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia (Nature Medicine)
  4. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment (Alzheimer's & Dementia)
  5. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. (Lancet Neurology)
  6. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (New England Journal of Medicine)
  7. Health Supervision for Children With Down Syndrome (Pediatrics)
  8. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia (Neurology)
  9. To err (meiotically) is human: the genesis of human aneuploidy (Nature reviews genetics)
  10. The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility. (Molecules and Cells)

Their papers